P50750 (CDK9_HUMAN) Homo sapiens (Human)
Cyclin-dependent kinase 9 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
28 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of HIV-1 Tat complexed with human P-TEFb |
Heteromer O60563; P04608; | 100.0 | 2×ZN; | |||
| Crystal structure of HIV-1 Tat complexed with ATP-bound human P-TEFb |
Heteromer O60563; P04608; | 100.0 | 1×ANP; 1×MG; 2×ZN; | |||
| Structure of full length CDK9 in complex with cyclinT and DRB |
Heteromer O60563; | 100.0 | ||||
| Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4 |
Heteromer O60563; P04608; Q9UHB7; | 100.0 | 8×YT3; 2×SO4; 2×ZN; | |||
| CDK9-Cyclin-T1 complex bound by compound 24 |
Heteromer O60563; | 97.45 | 1×Q6E; 1×TRS; 1×PO4; | |||
| The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat |
Heteromer O60563; Q9UHB7; | 100.0 | 1×AMP; | |||
| crystal structure of P-TEFb complex with AFF4 and Tat |
Heteromer O60563; P69698; Q9UHB7; | 100.0 | 1×ADN; 2×ZN; | |||
| HIV-1 TAR loop in complex with Tat:AFF4:P-TEFb |
Heteromer O60563; P04608; Q9UHB7; | 100.0 | 2×ZN; | |||
| CDK9/cyclin T1 in complex with KB-0742 |
Heteromer O60563; | 97.71 | 1×VQE; | |||
| TAR complex with HIV-1 Tat-AFF4-P-TEFb |
Heteromer O60563; P69697; Q9UHB7; | 100.0 | 2×ZN; | |||
| Structure of CDK9/cyclinT1 in complex with DRB |
Heteromer O60563; | 100.0 | 1×PO4; 5×GOL; 1×RFZ; | |||
| Structure of CDK9/CyclinT in complex with S-CR8 |
Heteromer O60563; | 100.0 | 1×SLQ; | |||
| Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer O60563; | 100.0 | 1×T3E; | |||
| Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer O60563; | 100.0 | 1×T7Z; 2×GOL; | |||
| Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer O60563; | 99.67 | 1×T6Q; | |||
| Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer O60563; | 100.0 | 1×T3C; 2×GOL; | |||
| Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer O60563; | 100.0 | 1×T9N; | |||
| CDK9/cyclin T in complex with CAN508 |
Heteromer O60563; | 100.0 | 1×F18; | |||
| Crystal structure of full-length cdk9 in complex with cyclin t |
Heteromer O60563; | 100.0 | ||||
| Structure of CDK9/cyclin T1 in complex with inhibitor |
Heteromer O60563; | 99.67 | 1×NJ6; | |||
| Crystal Structure of Human CDK9/cyclinT1 in complex with Flavopiridol |
Heteromer O60563; | 100.0 | 3×PO4; 1×CPB; | |||
| Crystal structure of CDK9-Cyclin T1 bound by compound 6 |
Heteromer O60563; | 100.0 | 1×UT5; | |||
| Crystal Structure of Human CDK9/cyclinT1 in complex with MC180295 |
Heteromer O60563; | 100.0 | 2×TO7; 2×TOJ; 1×PO4; | |||
| Crystal Structure of Human CDK9/cyclinT1 in Complex with ATP |
Heteromer O60563; | 100.0 | 1×MG; 1×ATP; 1×TRS; | |||
| Crystal Structure of Human CDK9/cyclinT1 with A86 |
Heteromer O60563; | 100.0 | 1×LCI; 2×GOL; | |||
| structure of CDK9/cyclin T F241L |
Heteromer O60563; | 100.0 | ||||
| Crystal Structure of Human CDK9/cyclinT1 |
Heteromer O60563; | 100.0 | 1×TRS; | |||
| CDK9/cyclin T in complex with CAN508 |
Heteromer O60563; | 100.0 | 3×PO4; 1×F18; 2×GOL; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3mi9.1.A | monomer | 0.84 | 100.00 | |||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 3mi9.1.A | monomer | 0.82 | 100.00 | |||